Ocular Therapeutix, Inc
OCUL- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001393434
In the last 90 days, Ocular Therapeutix, Inc insiders filed 0 open-market purchases and 5 sales; 262 institutions reported holding it in 13F filings for Q2 2026, worth $2.03B in total; no superinvestor holds it.
13F holders, Q3 2025
Institutional positions in Ocular Therapeutix, Inc as of Sep 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 216
- +32 vs. Q2 2025
- Shares held
- 188.2M
- +31.2M (+19.9%) vs. Q2 2025
- Total value
- $2.20B
- +$746.8M (+51.4%) vs. Q2 2025
- New holders
- 50
- 73 more added
- Sold out
- 18
- 58 more reduced
3 institutions that held it in Q2 2025 haven't filed for Q3 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting OCUL on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 262 | $2.03B |
| Q1 2026 | 271 | $1.77B |
| Q4 2025 | 249 | $2.33B |
| Q3 2025 | 216 | $2.20B |
| Q2 2025 | 187 | $1.45B |
| Q1 2025 | 197 | $1.01B |
| Q4 2024 | 180 | $1.14B |
| Q3 2024 | 168 | $1.22B |
| Q2 2024 | 151 | $939.8M |
| Q1 2024 | 147 | $1.12B |
| Q4 2023 | 119 | $328.8M |
| Q3 2023 | 114 | $127.0M |
| Q2 2023 | 135 | $224.2M |
| Q1 2023 | 127 | $213.8M |
| Q4 2022 | 116 | $111.3M |
| Q3 2022 | 130 | $177.6M |
| Q2 2022 | 123 | $178.2M |
| Q1 2022 | 132 | $215.4M |
| Q4 2021 | 140 | $289.1M |
| Q3 2021 | 141 | $445.7M |
| Q2 2021 | 149 | $685.8M |
| Q1 2021 | 154 | $774.9M |
Institutions, Q3 2025
Shares, value and share of portfolio for each institution holding Ocular Therapeutix, Inc; share changes are against Q2 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Geode Capital Management, LLC | 3,338,453 | $39.0M | 0.00% | +54,282+1.7% | Added |
| Alliancebernstein L.P. | 3,424,439 | $40.0M | 0.01% | +3,261,619+2,003.2% | Added |
| State Street Corp | 3,460,012 | $40.4M | 0.00% | −49,098−1.4% | Reduced |
| Paradigm Biocapital Advisors LP | 3,497,307 | $40.9M | 1.21% | +76,967+2.3% | Added |
| Millennium Management LLC | 3,855,706 | $45.1M | 0.04% | +3,736,560+3,136.1% | Added |
| Adage Capital Partners GP, L.L.C. | 4,004,350 | $46.8M | 0.07% | +114,173+2.9% | Added |
| Point72 Asset Management, L.P. | 4,601,321 | $53.8M | 0.12% | +2,697,107+141.6% | Added |
| Citadel Advisors LLC | 5,703,781 | $66.7M | 0.05% | +817,767+16.7% | Added |
| TCG Crossover Management, LLC | 6,117,232 | $71.5M | 3.52% | +798,084+15.0% | Added |
| Vanguard Group Inc | 9,163,240 | $107.1M | 0.00% | +771,065+9.2% | Added |
| Avoro Capital Advisors LLC | 10,250,000 | $119.8M | 1.55% | +2,850,000+38.5% | Added |
| BlackRock, Inc. | 10,556,837 | $123.4M | 0.00% | +10,458+0.1% | Added |
| Deep Track Capital, LP | 11,932,137 | $139.5M | 3.89% | −2,362,283−16.5% | Reduced |
| Summer Road LLC | 12,579,657 | $147.1M | 98.57% | −1,307,811−9.4% | Reduced |
| VR Adviser, LLC | 13,161,462 | $153.9M | 8.66% | +399,000+3.1% | Added |
| FMR LLC | 31,785,634 | $371.6M | 0.02% | +12,177,463+62.1% | Added |
| Franklin Resources Inc | 0 | $0 | 0.00% | −1,170,163−100.0% | Sold out |
| Pale Fire Capital SE | 0 | $0 | 0.00% | −530,135−100.0% | Sold out |
| AXA S.A. | 0 | $0 | 0.00% | −516,500−100.0% | Sold out |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −410,048−100.0% | Sold out |
| Panagora Asset Management Inc | 0 | $0 | 0.00% | −296,546−100.0% | Sold out |
| UBS Oconnor LLC | 0 | $0 | 0.00% | −210,205−100.0% | Sold out |
| IMC-Chicago, LLC | 0 | $0 | 0.00% | −207,765−100.0% | Sold out |
| Weiss Asset Management LP | 0 | $0 | 0.00% | −187,615−100.0% | Sold out |
| Banco Santander, S.A. | 0 | $0 | 0.00% | −184,048−100.0% | Sold out |
| Superstring Capital Management LP | 0 | $0 | 0.00% | −88,980−100.0% | Sold out |
| Y-Intercept (Hong Kong) Ltd | 0 | $0 | 0.00% | −36,815−100.0% | Sold out |
| Leonteq Securities AG | 0 | $0 | 0.00% | −25,000−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −11,950−100.0% | Sold out |
| Quantessence Capital LLC | 0 | $0 | 0.00% | −11,467−100.0% | Sold out |
| Ameritas Advisory Services, LLC | 0 | $0 | 0.00% | −291−100.0% | Sold out |
| SRS Capital Advisors, Inc. | 0 | $0 | 0.00% | −87−100.0% | Sold out |
| Twin Peaks Wealth Advisors, LLC | 0 | $0 | 0.00% | −2−100.0% | Sold out |
| Federated Hermes, Inc. | 0 | $0 | 0.00% | −2−100.0% | Sold out |
| Graypoint LLC | – | – | – | – | Not filed |
| CIBC World Markets Corp | – | – | – | – | Not filed |
| Atlas Capital Advisors LLC | – | – | – | – | Not filed |